Gyermekkori daganatok: vizsgálatok itt: Kína
611 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2/3. fázisCsak meghívásosComparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy
- Where
- Hangzhou
- Életkor
- 15 év to 65 év
- People
- 450
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07651163 - No phaseTaking peopleTwo-component Radiology-guided Autonomous Cascade Engine (TRACE)
- Where
- Shenyang
- People
- 54
- Run by
- Liaoning Cancer Hospital & Institute
See details and how to joinNCT07651644 - 2. fázisTaking peopleToripalimab Combined With CAV/IE Regimen
- Where
- Guangzhou
- Életkor
- 14 év to 70 év
- People
- 134
- Run by
- Sun Yat-sen University
See details and how to joinNCT04589741 - 1/2. fázisNot yet taking people in KínaPD-1 Antibody and JAK1 Inhibitor for Newly Diagnosed Pediatric Hodgikin's Lympoma
- Where
- Xuzhou
- Életkor
- 6 év to 18 év
- People
- 112
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07641010 - No phaseTaking peopleHaplo-Cord HSCT for AML/MDS
- Where
- Beijing, Chengdu, Fuzhou, Guangzhou
- Életkor
- 14 év to 60 év
- People
- 82
- Run by
- Fujian Medical University Union Hospital
See details and how to joinNCT07588360 - No phaseTaking peopleSymptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors
- Where
- Hangzhou
- Életkor
- 8 év to 18 év
- People
- 600
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07450872 - No phaseNot yet taking people in KínaComputer Vision-Based Recognition of Parathyroid Glands and Recurrent Laryngeal Nerves in Endoscopic Surgery
- Where
- Fuzhou
- People
- 100
- Run by
- Fujian Medical University
See details and how to joinNCT07628543 - 2/3. fázisTaking peopleChemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents
- Where
- Shanghai
- Életkor
- Up to 18 év
- People
- 87
- Run by
- Children's Cancer Group, China
See details and how to joinNCT07168980 - No phaseTaking peopleAssociation Between Screening Behaviors and Lung Cancer Spectrum
- Where
- Shanghai
- People
- 5390
- Run by
- Fudan University
See details and how to joinNCT07626177 - No phaseTaking peopleMechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer
- Where
- Beijing
- People
- 80
- Run by
- Peking University People's Hospital
See details and how to joinNCT07359040 - No phaseNot yet taking people in KínaStructured Cardio-Oncology Rehabilitation for Cardiovascular Outcomes in Cancer Survivors
- Where
- Ürümqi
- Életkor
- 18 hónap and over
- People
- 800
- Run by
- Xinjiang Medical University
See details and how to joinNCT07622394 - 1. fázisNot yet taking people in KínaSingle-arm, Open-label, Dose-escalating Phase I Clinical Study of PA3-17 Injection in Children and Adolescents With Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma
- Where
- Hefei
- Életkor
- 3 év to 18 év
- People
- 12
- Run by
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT07623681 - No phaseNot yet taking people in KínaNeoadjuvant Radiotherapy and Surgery for High-Risk Localized Ewing Sarcoma
- Where
- Beijing
- Életkor
- 12 hónap and over
- People
- 55
- Run by
- Peking University People's Hospital
See details and how to joinNCT07620431 - 2. fázisNot yet taking people in KínaPreoperative Radiotherapy and Anlotinib With or Without Penpulimab for Soft Tissue Sarcoma
- Where
- Beijing
- Életkor
- 15 év and over
- People
- 274
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07612098 - 1/2. fázisTaking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Daping, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Nanjing, Shanghai, Shatin, Shenyang, Shenzhen, Taiyuan, Weifang, Wuhan, Xiamen, Xi'an, Xuzhou, Zhengzhou
- Életkor
- 12 év and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - No phaseTaking peopleMulticentric Database for KRAS Mutant Pancreatic Cancer
- Where
- Shanghai
- People
- 1000
- Run by
- Fudan University
See details and how to joinNCT07557849 - 1. fázisTaking peopleOptimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia
- Where
- Beijing, Chengdu, Shanghai
- Életkor
- 1 év to 70 év
- People
- 27
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT06326021 - 2. fázisTaking peopleCryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma
- Where
- Guangzhou
- Életkor
- 14 év to 70 év
- People
- 57
- Run by
- Sun Yat-sen University
See details and how to joinNCT07602049 - No phaseNot yet taking people in KínaAnalysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy
- Where
- Beijing, Shenzhen, Taiyuan
- Életkor
- 1 év and over
- People
- 300
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07596524 - 2. fázisTaking peopleDoxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study
- Where
- Guangzhou
- Életkor
- 6 hónap to 18 év
- People
- 88
- Run by
- Sun Yat-sen University
See details and how to joinNCT05457829 - No phaseNot yet taking people in KínaProspective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection
- Where
- Wuhan
- People
- 1000
- Run by
- Tongji Hospital
See details and how to joinNCT07593833 - 1/2. fázisTaking peopleVenetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML
- Where
- Tianjin
- Életkor
- 14 év and over
- People
- 23
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06611839 - 2. fázisTaking peopleEfficacy of Venetoclax Combined With Intensive Chemotherapy in Different Subgroups of AML
- Where
- Tianjin
- Életkor
- 14 év to 60 év
- People
- 380
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06635681 - No phaseTaking peopleABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
- Where
- Tianjin
- Életkor
- 14 év to 60 év
- People
- 92
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07454226 - 1. fázisTaking peoplePhase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
- Where
- Guangzhou
- Életkor
- 2 év to 18 év
- People
- 51
- Run by
- Sun Yat-sen University
See details and how to joinNCT07584499